Search results for " pharmaceutical" in Articles / App Notes
Article
Platform Technologies Improve Protein Expression
…ake protein-based drugs with appropriate post-translational modifications that meet the needs of the pharmaceutical industry, physicians, and ultimately patients in need of novel medications,” notes …
Article
Avoiding Investigational Failures and Discrepancies
As referenced in FDA’s Quality Systems Approach to Pharmaceutical CGMP Regulations guidance, an “investigation” refers to the formal procedural process evaluation of a problem resolution (2). The Form…
Article
The New World of Biopharmaceutical Manufacturing
Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment.
By Jennifer Markarian
…
Article
Unifying Continuous Biomanufacturing Operations
Lawrence Yu, PhD, deputy director in the Office of Pharmaceutical Quality at the Center for Drug Evaluation and Research (CDER), said in a 2016 FDA blog post that processes that take a month with fed-…
Article
Fusion Proteins Pose Manufacturability Challenges
Solutions for overcoming these issues are being developed in academia and the pharmaceutical industry by equipment vendors and drug companies alike.
Making proteins ‘druggable’
Many proteins…
Article
Critical Quality Attributes Challenge Biologics Development
…ibb and Finance Committee member and past-chair of the BIOTEC Section at the American Association of Pharmaceutical Scientists (AAPS), about how CQAs for biologics differ from CQAs for small-molecule…
Article
Ensuring the Biological Integrity of Raw Materials
It has only been used by a few pharmaceutical production facilities as yet, according to Michael Sasges, a research engineer at Trojan Technologies. “It’s a conservative and highly regulated industry,…
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
Last year also marked a significant step towards integrating continuous manufacturing into pharmaceutical production for a small-molecule drug when FDA approved, for the first time, a manufacturer’s c…
Article
The Tide Stays High
Deloitte, Balancing the R&D Equation: Measuring the Return from Pharmaceutical Innovation 2016.
Article
Innovation vs. Capacity: How CMOs Compete
…national, or local markets with limited experience with major regulatory regimes (FDA, EMA, Japanese Pharmaceuticals and Medical Devices Agency [PMDA]) outside of their home region
• In many case…